No abstract available
MeSH terms
-
Alemtuzumab
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm / therapeutic use*
-
Antigens, CD / drug effects
-
Antigens, Neoplasm / drug effects
-
Antineoplastic Agents / therapeutic use*
-
CD52 Antigen
-
Clinical Trials as Topic
-
Glycoproteins / drug effects
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Remission Induction
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Neoplasm
-
Antigens, CD
-
Antigens, Neoplasm
-
Antineoplastic Agents
-
CD52 Antigen
-
CD52 protein, human
-
Glycoproteins
-
Alemtuzumab